SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-24-057903
Filing Date
2024-03-04
Accepted
2024-03-04 16:28:57
Documents
1
Effectiveness Date
2024-03-04

Document Format Files

Seq Description Document Type Size
1 S-8 POS d792308ds8pos.htm S-8 POS 39454
  Complete submission text file 0001193125-24-057903.txt   40747
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
PHAXIAM Therapeutics S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-265927 | Film No.: 24715306
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)